United States · 
What does Jennison Associates invest in?
Jennison Associates invests most often at Series B and Series C (65% of the rounds on record), in sectors such as Mobile and Wireless.
Jennison Associates highlights
- 01
17 rounds on record
- 02
Mostly Series B and Series C: 65% of its rounds
- 03
2 exits from the portfolio
What they do
- Type
- Growth equity (from a list, unverified)
- Cheque size
- Not stated
- Stages
- SeedSeries ASeries BGrowthPre-IPO
- Sectors
- MobileWireless
- Based in
- New York, United States
- Cold pitches
- Not stated
The record
Every round we can evidence, newest first17 appearances
- 2015
10 rounds
- Aug
- Aug
- Aug
- Aug
- Jul
- Jul
- Jun
- May
- Apr
- Apr
- 2014
4 rounds
- Nov
- Sept
- Aug
- Apr
- 2013
1 round
- Mar
- 2011
1 round
- Apr
- 2006
1 round
- Aug
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
The team
Named by the firm itself, on a filing, its Form ADV or its company registration10 named
DADavid Alexander HuntDirectoriForm ADV
HAHeather Amy KadenManaging Director & Chief Compliance OfficeriForm ADV
JVJanice VrdoljakManaging Director & Chief Financial OfficeriForm ADV
JTJeffrey Todd BeckerChairman, Director & Chief Executive OfficeriForm ADV
JMJurgen MuhlhauserDirectoriForm ADV
KAKathleen Ann MccarragherManaging Director, Head of Growth Equity & DirectoriForm ADV
KMKenneth MooreExecutive Vice President, Treasurer, Chief Operating Officer & DirectoriForm ADV
MMMirry Melissa HwangManaging Director, Secretary & Chief Legal OfficeriForm ADV
PMPamela Margaret SinclairDirectoriForm ADV
THTaimur HyatDirectoriForm ADV
We also hold 29 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.
What the register says
From the firm's own filings with the SEC, which it must file accurately by law
$215Bassets it managesOct 2026
Registeredinvestment adviserfull reporting to the SEC
- Legal name
- Jennison Associates LLC
- SEC number
- CRD 107959
Funds on its Form ADV
8 private funds, $5.7B in gross assets · filed Dec 2024
Trust company collective inv 6Hedge 2
- Invesco Fixed Income Trust Jennison Intermediate FundTrust company collective inv2 investors$4.4B
- Jennison Growth Equity Fund of the Prudential Trust Company Institutional Business TrustTrust company collective inv6 investors$409M
- Jennison Global Opportunity Fund of the Prudential Trust Company Institutional Business TrustTrust company collective inv11 investors$358M
- Jenop Global Healthcare Fund LimitedHedge43 investors$252M
- Jennison Global Healthcare Master Fund, LTD.Hedge29 investors$216M
- Jennison U.S. Small CAP Equity Fund of the Prudential Trust Company Institutional Business TrustTrust company collective inv3 investors$50M
- Jennison Christian SRI Small/Mid CAP Core Equity Fund of the Prudential Trust Company Institutional Business TrustTrust company collective inv2 investors$26M
- Jennison Small/Mid CAP Fund of the Prudential Trust Company Institutional Business TrustTrust company collective inv1 investor$6.8M
Exits from the portfolio
Companies it backed that were later bought or listed2 in all
PTC TherapeuticsListed$125MJun 2013
Merrimack PharmaceuticalsListedUndisclosedMar 2012
An exit counts when it came after the firm's first round in the company. From historical deal records.